Back to search results

Cadherin 3(CDH3)-Targeted PET in Lung Malignant Tumors

Abroad (travel likely)Recruiting

Conditions

Non-Small Cell Lung Cancer · Malignant Neoplasm · Pulmonary Nodules · PET/CT

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
Study leads

  • Kezhong Chen, MD

    Study Director

    Peking University People's Hospital

  • Jun Wang, M.M.

    Study Chair

    Peking University People's Hospital

  • Xing Yang, MD

    Principal Investigator

    Peking University People's Hospital

  • Yuan Li, MD

    Principal Investigator

    Peking University People's Hospital

  • Hao Li, MD

    Principal Investigator

    Peking University People's Hospital

  • Ziqian Bai, MD

    Principal Investigator

    Peking University People's Hospital

View source on ClinicalTrials.gov(opens in a new tab)